ABVC BioPharma, Inc. (ABVC) Q4 2024 Earnings
ABVC·Reported April 15, 2025·Before market open
ABVC BioPharma, Inc. reported Q4 2024 revenue of $2.0K. Diluted EPS came in at $0.04.
Revenue
$2.0K
Diluted EPS
$0.04
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about ABVC BioPharma, Inc.'s Q4 2024 earnings report.
ABVC BioPharma, Inc. (ABVC) reported Q4 2024 earnings on April 15, 2025 before market open.
ABVC BioPharma, Inc. reported revenue of $2.0K and diluted EPS of $0.04 for Q4 2024.